Stocks and Investing Stocks and Investing
Tue, June 6, 2023
Mon, June 5, 2023
Sat, June 3, 2023
Fri, June 2, 2023

Brian Abrahams Reiterated (BIIB) at Buy and Held Target at $340 on, Jun 2nd, 2023


Published on 2024-10-28 04:10:21 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Reiterated "Biogen Inc." (BIIB) at Buy and Held Target at $340 on, Jun 2nd, 2023.

Brian has made no other calls on BIIB in the last 4 months.



There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $263 on, Tuesday, May 23rd, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $320 on, Thursday, May 4th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $282 on, Wednesday, April 26th, 2023
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $302 on, Wednesday, April 26th, 2023


These are the ratings of the 11 analyists that currently disagree with Brian


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $360 on, Thursday, June 1st, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Thursday, May 11th, 2023
  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Increased Target to $350 on, Monday, May 1st, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Wednesday, April 26th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $330 on, Wednesday, April 26th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $371 on, Wednesday, April 26th, 2023
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $321 on, Wednesday, April 26th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, April 26th, 2023
  • Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023